| 2025年年报 | 2024年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 医药批发(元) | 389,761,529.52 | 574,028,328.57 |
| 医药生产(元) | 1,796,399,396.26 | 2,026,899,045.34 |
| 其他贸易(元) | 23,874,058.11 | 50,589,281.84 |
| 营业成本(元) | ||
| 医药批发(元) | 363,796,699.87 | 541,250,998.67 |
| 医药生产(元) | 657,799,970.96 | 685,770,015.86 |
| 其他贸易(元) | 17,190,920.76 | 40,830,968.45 |
| 毛利(元) | ||
| 医药批发(元) | 25,964,829.65 | 32,777,329.90 |
| 医药生产(元) | 1,138,599,425.30 | 1,341,129,029.48 |
| 其他贸易(元) | 6,683,137.35 | 9,758,313.39 |
| 毛利率(%) | ||
| 医药批发(%) | 6.66 | 5.71 |
| 医药生产(%) | 63.38 | 66.17 |
| 其他贸易(%) | 27.99 | 19.29 |
| 收入构成(%) | ||
| 医药批发(%) | 17.64 | 21.65 |
| 医药生产(%) | 81.28 | 76.44 |
| 其他贸易(%) | 1.08 | 1.91 |
| 毛利构成(%) | ||
| 医药批发(%) | 2.22 | 2.37 |
| 医药生产(%) | 97.21 | 96.93 |
| 其他贸易(%) | 0.57 | 0.71 |